SLN124
SLN124-002
Phase 1 small_molecule completed
Quick answer
SLN124 for Non-transfusion-dependent Thalassemia is a Phase 1 program (small_molecule) at Silence Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Silence Therapeutics plc
- Indication
- Non-transfusion-dependent Thalassemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed